MA06.07 Patterns of Progression with Lorlatinib and Insights into Subsequent Anticancer Therapy Efficacy in Advanced ALK+ NSCLC
Tony Mok, B.J. Solomon, M.R. García Campelo, Yonghe Wu et autres
hk, au, es, cn, ar, cz, fr, ua, tw, it, us (code pays fourni par la source)